Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
12.79
-0.25 (-1.92%)
Nov 21, 2024, 4:00 PM EST - Market closed
Rocket Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -258.08 | -245.6 | -221.86 | -169.07 | -139.7 | -77.27 | |
| Depreciation & Amortization | 8.95 | 7.1 | 6.27 | 5.37 | 6.25 | 0.43 | |
| Other Amortization | - | - | - | 0.75 | 2.76 | 3.6 | |
| Asset Writedown & Restructuring Costs | 0.02 | 0.89 | 0.24 | 0.26 | 0.42 | - | |
| Loss (Gain) From Sale of Investments | -9.94 | -10.17 | 0.13 | 2.89 | 0.58 | -1.07 | |
| Stock-Based Compensation | 42.76 | 39.41 | 31.01 | 29.24 | 18.57 | 13.37 | |
| Other Operating Activities | - | - | - | 12.78 | 26.56 | - | |
| Change in Accounts Payable | 21.05 | 10.15 | 9.67 | -4.83 | 11.02 | -2.72 | |
| Change in Other Net Operating Assets | 3.11 | 3.31 | -3.6 | 1.44 | -1.09 | -1 | |
| Operating Cash Flow | -192.12 | -194.92 | -178.14 | -121.16 | -74.64 | -64.66 | |
| Capital Expenditures | -10.2 | -16.44 | -8.36 | -7.62 | -20.61 | -23.27 | |
| Cash Acquisitions | - | - | 42.73 | - | - | - | |
| Investment in Securities | 38.97 | -81.59 | -103.43 | 26.57 | -67.53 | -15.74 | |
| Other Investing Activities | - | -0.04 | -0.26 | -0.1 | -8.45 | - | |
| Investing Cash Flow | 28.77 | -98.07 | -69.33 | 18.85 | -96.59 | -39.01 | |
| Issuance of Common Stock | 3.28 | 208.4 | 155.34 | 37.68 | 283.91 | 178.14 | |
| Repurchase of Common Stock | - | - | -0.05 | - | -0.69 | -0.34 | |
| Other Financing Activities | - | - | - | - | -0.24 | - | |
| Financing Cash Flow | 3.28 | 208.4 | 155.29 | 37.68 | 282.99 | 177.79 | |
| Net Cash Flow | -160.07 | -84.58 | -92.18 | -64.63 | 111.76 | 74.12 | |
| Free Cash Flow | -202.32 | -211.35 | -186.5 | -128.78 | -95.25 | -87.93 | |
| Free Cash Flow Per Share | -2.16 | -2.52 | -2.74 | -2.04 | -1.72 | -1.79 | |
| Cash Interest Paid | - | - | - | 0.15 | 2.96 | 2.99 | |
| Cash Income Tax Paid | - | - | - | - | - | 0.03 | |
| Levered Free Cash Flow | -120.67 | -121.64 | -97.45 | -82.57 | -74.19 | -55.33 | |
| Unlevered Free Cash Flow | -119.5 | -120.47 | -96.29 | -81.47 | -72.6 | -55.21 | |
| Change in Net Working Capital | -10.11 | -11.75 | -12.7 | 4.55 | -7.13 | -1.7 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.